Cyrusone Inc (CONE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CONE Annual Balance Sheets →
From Cyrusone Inc through Dec 31 2020, shifts in Dec 31 2021's assets and liabilities provide insight into the company's capital structure and financial stability.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2021)
(Sep 30 2021) (Jun 30 2021) (Mar 31 2021) (Dec 31 2020)
Assets
Cash & cash equivalent346.30
Cash & Short-term Investments346.00
Accounts receivable420.40
Premiums and Other Receivables, Net, Total0.00
Total Current Assets766.70
Equipment/Property/Plant Net4,350.80
Goodwill net455.10
Intangible Assets124.80
Long-term investments5,577.90
Other Assets, Noncurrent1,754.60
Total Assets7,452.00
Liabilities
Accrued Liabilities, Current192.80
Total Current Liabilities192.80
Long-term debt3,492.90
Total Long-term Debt3,492.90
Other liabilities, Noncurrent842.60
Total Liabilities4,528.30
Stockholders' Equity
Common Stock Value1.30
Additional Paid In Capital Common Stock4,145.10
Retained Earnings / Accumulated Deficit-1,200.10
Other Equity-22.60
Common Stockholder's Equity2,923.70
Total Stockholder's Equity2,923.70
Liabilities & Stockholder's Equity7,452.00
4 historic quarters locked

Sign in to unlock the full Cyrusone Inc balance sheet history.

About Cyrusone Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-22-037016

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.